KWMG
TEVA icon

King Wealth Management Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

King Wealth Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.39M Sell
100,000
-10,000
-9% -$333K 0.37% 42
2026
Q1 		$3.31M Sell
110,000
-25,000
-19% -$804K 0.41% 41
2025
Q4 		$4.21M Sell
135,000
-25,000
-16% -$616K 0.51% 36
2025
Q3 		$3.23M Sell
160,000
-45,000
-22% -$790K 0.41% 39
2025
Q2 		$3.44M Buy
205,000
+30,000
+17% +$484K 0.47% 37
2025
Q1 		$2.69M Buy
175,000
+160,500
+1,107% +$2.87M 0.41% 39
2024
Q4 		$3.2M Sell
14,500
-83,602
-85% -$1.52M 0.47% 40
2024
Q3 		$1.77M Buy
+98,102
New +$1.72M 0.28% 44
2016
Q2 		– Sell
-23,357
Closed -$1.25M – 108
2016
Q1 		$1.25M Sell
23,357
-599
-3% -$35.1K 0.67% 34
2015
Q4 		$1.57M Sell
23,956
-576
-2% -$35.6K 0.87% 28
2015
Q3 		$1.39M Buy
24,532
+859
+4% +$55.7K 0.85% 28
2015
Q2 		$1.4M Sell
23,673
-649
-3% -$40K 0.77% 31
2015
Q1 		$1.51M Sell
24,322
-4,498
-16% -$262K 0.87% 28
2014
Q4 		$1.66M Buy
28,820
+1,508
+6% +$84K 0.88% 31
2014
Q3 		$1.47M Buy
27,312
+352
+1% +$18.6K 0.92% 28
2014
Q2 		$1.42M Buy
26,960
+636
+2% +$32.5K 0.88% 30
2014
Q1 		$1.39M Buy
+26,324
New +$1.22M 0.96% 27

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

King Wealth Management Group's TEVA Position: Q2 2026 in Review

King Wealth Management Group reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 9.1% in Q2 2026, selling an estimated $333K and leaving 100,000 shares worth $3.39M. The position accounts for 0.37% of the portfolio, ranked #42.

King Wealth Management Group first reported a position in TEVA in Q1 2014 and has held it in 17 quarters since. The position peaked at $4.21M in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • King Wealth Management Group held 100,000 shares of Teva Pharmaceutical Industries Limited worth $3.39M as of Q2 2026.
  • King Wealth Management Group sold 10,000 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $333K.
  • Teva Pharmaceutical Industries Limited made up 0.37% of King Wealth Management Group's portfolio in Q2 2026, its #42 holding.
  • King Wealth Management Group first reported a position in Teva Pharmaceutical Industries Limited in Q1 2014 and has held it in 17 quarters since.
  • King Wealth Management Group's Teva Pharmaceutical Industries Limited position peaked at $4.21M in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on King Wealth Management Group's 13F filing for Q2 2026, filed 5 Aug 2026.